Latest News
09 Feb
New York Stock Exchange, NYSE, markets, Wall Street
US close: Stocks mixed amid corporate earnings, impeachment trial

Wall Street stocks turned in a mixed performance on Tuesday amid more corporate earnings and Donald Trump's second impeachment trial.

09 Feb
micro focus
Sector movers: Technology issues, Homebuilders pace gains

Technology issues performed best on Tuesday helped by fresh record highs for the tech-heavy Nasdaq Composite index on Wall Street.

09 Feb
la-fed-fixe-les-besoins-de-fonds-propres-supplementaires-pour-les-grandes-banques-americaines
Wednesday preview: China CPI, Fed's Powell in focus

Financial markets' focus in the middle of the week will shift to readings for consumer price inflation from around the world and speeches from the heads of several of the world's main central banks.

09 Feb
ep instalaciones de refino de marathon petroleum
Europe close: Oil and Gas, Travel names drag on indices

European shares finished on a mixed note on Tuesday as investors booked profits following the rally seen during the last few days, driven by vaccine roll-outs and hopes the US Covid-19 relief package would make swift progress through Congress.

09 Feb
ocado jobs work employment
London close: Stocks eke out gains, Ocado finishes weaker

London stocks were barely in the green by the close on Tuesday, with online supermarket Ocado finishing weaker after its full-year results.

09 Feb
ep logo de general motors
GM extends production cuts due to global chip shortage

General Motors said on Tuesday it was extending production cuts at three North American plants until at least mid-March due to the shortage in semiconductor chips that is affecting companies worldwide.

09 Feb
la-fed-fixe-les-besoins-de-fonds-propres-supplementaires-pour-les-grandes-banques-americaines
US job openings and 'quits' rate rise in December

US companies hired fewer people at the end of 2020, but in a slightly positive omen for the economy, the number of job openings increased.

09 Feb
20141030 122019 opt 1 opt
Director dealings: Manolete Partners CEO lowers stake

Manolete Partners revealed on Tuesday that chief executive Steven Cooklin had disposed of 750,000 ordinary shares in the AIM-listed insolvency litigation financier.

09 Feb
asos sede logo
Broker tips: SolGold, Spirent Communications, Asos, Electrocomponents

Analysts at Liberum lowered their target price on mining outfit SolGold from 55. 0p to 39. 0p on Tuesday after the group again delayed publication of a pre-feasibility study.

09 Feb
micro focus
FTSE 250 movers: Micro Focus surges as it reinstates divi; travel stocks fall

London’s FTSE 250 was up 0. 1% at 21,114. 18 in afternoon trade on Tuesday.

09 Feb
wall street
US open: Stocks mixed as earnings, stimulus and impeachment trial all in focus

Wall Street stocks were mixed after the opening bell on Tuesday amid more corporate earnings and Donald Trump's second impeachment trial.

09 Feb
coins currency investment insurance business finance company
Eqtec inks collaboration deal with Logik Developments

Waste-to-energy gasification technology company Eqtec has signed a collaboration framework agreement with Logik Developments, it announced on Tuesday.

09 Feb
ocado jobs work employment
FTSE 100 movers: Housebuilders rally; Ocado drops after results

London’s FTSE 100 was up 0. 1% at 6,531. 86 in afternoon trade on Tuesday.

09 Feb
cboro shdr11
Altus Strategies granted four exploration licences in Egypt

Altus Strategies announced the granting of four gold exploration licences comprising nine licence blocks on Tuesday, totalling 1,565 square kilometres, in the Eastern Desert of Egypt.

09 Feb
ep tedros adhanom ghebreyesus director general of the world health organization who
WHO claims animals 'most likely' origin of SARS-CoV-2

World Health Organization scientists who have been studying the origin of the Covid-19 virus in China over the past four weeks concluded that the most likely origin of the illness was in animals.

09 Feb
ep recurso de laboratorio reig jofre 20200910081804
Sensyne Health signs licence agreement with Excalibur

Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's ‘MagnifEye’ system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.

09 Feb
ep singapore airlines 20171024174003
Airbus, Boeing lose $3bn as Singapore Airlines defers spending

Singapore Airlines Ltd said on Tuesday it would defer over $3. 01bn of spending on Airbus SE and Boeing Co. planes after reaching agreements with the aircraft manufacturers to delay deliveries.

09 Feb
ep imagen de un concesionario de honda
Honda, Nissan strengthen full-year guidance as global demand picks up

Japanese car makers Nissan and Honda strengthened their full-year forecasts on Tuesday, supported in part by improving demand from China.

09 Feb
electrocomponents warehouse distribution
Tuesday broker round-up

Spirent Communications: Canaccord upgrades to buy with a target price of 275p.

09 Feb
coronavirus-l-ue-veut-boucler-les-discussions-preliminaires-avec-valneva-cette-semaine
US small business confidence dips in January, survey shows

Small business confidence in the US dipped at the start of the year with many company owners downbeat after Democrats won the presidential election and new Covid-19 cases surged, the results of a closely-followed survey revealed.

News Source: © 2022 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.